North America Cell Line Development Market 2027 By Type, By Product, Application, and Geography

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027

North America Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography

Report Date : Feb 2020
Report Code : TIPRE00009033

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 145

Page Updated: Feb 2020

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

Cell Line Development market in North America is expected to grow from US$ 1,393.32 Mn in 2019 to US$ 3,829.46 Mn by the year 2027. This represents a CAGR of 13.5% from the year 2020 to 2027.

The growth of the Cell Line Development market is driven by the factors such as increase in the demand for innovative products from biopharmaceutical and biotechnology companies, the presence of key market players, and extensive R&D conducted by various academic and research institutes in the North America region.

The medical biotechnology has undergone revolutions as a result of various development programs, business strategies that helps to produce, discover, or alter various biomolecules and organisms through bioengineering approaches. The Biotech Startup Revolution has also assisted in promoting the new ventures holding promising and innovative ideas in the country and supported in maximizing the revenue generation and thus the economic position of North America in the global cell line development market.

Moreover, increasing focus on advanced method incorporation in healthcare, government, and private initiatives for promotion of precision medicine and massive funds from government and private bodies for genomic research are further expected to stimulate growth and contribute to exceptional revenue generation for the cell line development market in North America.

US is anticipated to lead the adoptions of cell line development across the North American region through the forecast period. The increasing investments and rising funds dedicated to the manufacturing companies as well as academic and research institutes for the development of cell line based end products such as precision medicine and other therapeutics is one of the major driving factors. In 2018, The All of Us Research Program of NIH funded the Genome Centers in generating genotype sequence data from bio samples. These factors are expected to accelerate market growth over the forecast years.

Mexico Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

NORTH AMERICA CELL LINE DEVELOPMENT - MARKET SEGMENTATION

North America Cell Line Development Market - By Type

Recombinant Cell Line
Hybridomas
Primary Cell Line
Continuous Cell Lines

North America Cell Line Development Market - By Product

Media and Reagent
Equipment

North America Cell Line Development Market - By Application

Bioproduction
Drug Discovery
Tissue Engineering

North America Cell Line Development Market - By Country

U.S.
Canada
Mexico

Companies Mentioned

Merck KGaA
Thermo Fisher Scientific, Inc.
Sartorius AG
SELEXIS
BioFactura, Inc.
WuXi AppTec
LakePharma, Inc.
General Electric Company
Lonza
Corning Incorporated

North America Cell Line Development Report Scope

Report Attribute	Details
Market size in 2019	US$ 1,393.32 Million
Market Size by 2027	US$ 3,829.46 Million
Global CAGR (2020 - 2027)	13.5%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Type Primary Cell Line Hybridomas Continuous Cell Lines Recombinant Cell Line By Product Equipment and Media & Reagent By Application Drug Discovery Bioproduction and Tissue Engineering
Regions and Countries Covered	North America US Canada Mexico
Market leaders and key company profiles	Merck KGaA Thermo Fisher Scientific, Inc. Sartorius AG SELEXIS BioFactura, Inc. WuXi AppTec LakePharma, Inc. General Electric Company

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the North America Cell Line Development Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy